Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 1/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.66 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.60 |
| ▸ | ENPP2 | Q13822 | 6/20 | 0.59 |
| ▸ | SUMO2 | P61956 | 1/20 | 0.57 |
| ▸ | SUMO1 | P63165 | 1/20 | 0.57 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.57 |
| ▸ | SENP2 | Q9HC62 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | CD40 | P25942 | 1/20 | 0.51 |
| ▸ | CD40LG | P29965 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GRK2 | P25098 | 1/20 | 0.50 |
| ▸ | PLEC | Q15149 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2161281 | 1.00 | PRMT1 (0.74) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL9273205 | 0.99 | PRMT1 (0.73) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL9273197 | 0.99 | PRMT1 (0.73) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL29399950 | 0.99 | PRMT1 (0.73) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL11791675 | 0.99 | PRMT1 (0.73) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL18888951 | 0.93 | PRMT1 (0.65) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL5351115 | 0.92 | CYP1A2 (0.71) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL5351119 | 0.92 | CYP1A2 (0.71) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL24279794 | 0.91 | CYP1A2 (0.70) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 | |
| SCHEMBL5859444 | 0.91 | CYP1A2 (0.70) | PRMT1CYP1A2CYP2C9MAPK1DNASE1L3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3366750-B1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2021-07-21 | — | — | EP | claimed |
| US-10961185-B2 | Stabilizer and stabilization method | FUJIFILM WAKO PURE CHEMICAL CHEMICAL CORPORATION (JP) | 2021-03-30 | — | — | US | claimed |
| CN-108138047-B | Stabilizer and stabilization method | 富士胶片和光纯药株式会社 | 2021-02-09 | — | — | CN | claimed |
| US-20180290969-A1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM WAKO PURE CHEMICAL CHEMICAL CORPORATION (JP) | 2018-10-11 | — | — | US | claimed |
| EP-3366750-A1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM Wako Pure Chemical Corporation (JP) | 2018-08-29 | — | — | EP | claimed |
| WO-2000038631-A1 | AGENT FOR DYING KERATIN FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-07-06 | — | — | WO | claimed |
| WO-1990015816-A1 | SURAMIN TYPE COMPOUNDS AND ANGIOSTATIC STEROIDS TO INHIBIT ANGIOGENESIS | THE UPJOHN COMPANY (US) | 1990-12-27 | — | — | WO | claimed |
| EP-3366750-B1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2021-07-21 | — | — | EP | disclosed |
| US-10961185-B2 | Stabilizer and stabilization method | FUJIFILM WAKO PURE CHEMICAL CHEMICAL CORPORATION (JP) | 2021-03-30 | — | — | US | disclosed |
| US-20180290969-A1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM WAKO PURE CHEMICAL CHEMICAL CORPORATION (JP) | 2018-10-11 | — | — | US | disclosed |
| EP-3366750-A1 | STABILIZER AND STABILIZATION METHOD | FUJIFILM Wako Pure Chemical Corporation (JP) | 2018-08-29 | — | — | EP | disclosed |
| US-8277801-B2 | Delivery system for functional compounds | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2012-10-02 | — | — | US | disclosed |
| US-20100215754-A1 | Delivery System for Functional Compounds | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2010-08-26 | — | — | US | disclosed |
| US-5885362-A | APPLYING TO SURFACE A COMPOSITION COMPRISING A LIQUID MEDIUM AND AT LEAST ONE COMPLEXING AGENT, FOR EXAMPLE ETHYLENEDIAMINEDIORTHOHYDROXYPHENYLACETIC ACID | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-03-23 | — | — | US | disclosed |
| US-5790627-A | Method and apparatus for observing a specimen using an X-ray microscope | RESEARCH DEVELOPMENT CORP. (JP) | 1998-08-04 | — | — | US | disclosed |
| WO-1997041844-A1 | COMBINATIONS OF ANGIOSTATIC COMPOUNDS | ALCON LABORATORIES, INC. (US) | 1997-11-13 | — | — | WO | disclosed |
| EP-0789071-A1 | METHOD FOR TREATING SURFACE OF SUBSTRATE AND SURFACE TREATMENT COMPOSITION THEREFOR | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-08-13 | — | — | EP | disclosed |
| EP-0477195-A1 | SURAMIN TYPE COMPOUNDS AND ANGIOSTATIC STEROIDS TO INHIBIT ANGIOGENESIS | THE UPJOHN COMPANY (US) | 1992-04-01 | — | — | EP | disclosed |
| WO-1990015816-A1 | SURAMIN TYPE COMPOUNDS AND ANGIOSTATIC STEROIDS TO INHIBIT ANGIOGENESIS | THE UPJOHN COMPANY (US) | 1990-12-27 | — | — | WO | disclosed |
| US-4361842-A | INK JET | CANON KABUSHIKI KAISHA (JP) | 1982-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180290969-A1 | STABILIZER AND STABILIZATION METHOD | H1-0, H1-2, H1-4 | PRMT1 156/4885CYP1A2 2913/4885CYP2C9 4376/4885 |
| US-10961185-B2 | Stabilizer and stabilization method | H1-0, H1-2, H1-4 | PRMT1 156/4885CYP1A2 2913/4885CYP2C9 4376/4885 |
| US-20100215754-A1 | Delivery System for Functional Compounds | OR51E2, HAVCR2, AKR7A2 | PRMT1 2445/4885CYP1A2 154/4885CYP2C9 649/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.